The impact of Human Immunodeficiency Virus and Human Papillomavirus Co-Infection on HPV genotype distribution and cervical lesion grade in a semi-urban population in Tigoni, Kenya

Abstract/Overview

Background: Cervical cancer, a common cause of death among women, is attributable to human papilloma virus (HPV). Human immunodeficiency virus (HIV) infection can potentially alter the incidence of cervical cancer. Prophylactic HPV vaccines are a major advance against cervical cancer. Epidemiological research on HPV and cervical cancer is therefore justified. Objective: To determine the impact of HIV and HPV co-infection on the HPV genotype distribution and cervical lesion grade in Tigoni, Kenya. Methodology: This was a cross-sectional study. Women aged 25 to 60 years were invited for cervical cancer and HIV screening. HPV typing was done by PCR on residual cervical samples after cytology reporting. Results: Of 438 samples, 140 (31.96%) were positive for at least one type of HPV. The most frequent HPV types were 16, 56, 53, 35, and 39. When co-infection with HIV was examined, 37 (32.5%) were HPV-/HIV+, 63 (19.4%) were HPV+/HIV-, 77 (67.5%) were HPV+/HPV+ (p

Subscribe to access this work and thousands more
Overall Rating

0

5 Star
(0)
4 Star
(0)
3 Star
(0)
2 Star
(0)
1 Star
(0)
APA

<div>Sekkade-Kigondu, < (2024). The impact of Human Immunodeficiency Virus and Human Papillomavirus Co-Infection on HPV genotype distribution and cervical lesion grade in a semi-urban population in Tigoni, Kenya. Afribary. Retrieved from https://tracking.afribary.com/works/the-impact-of-human-immunodeficiency-virus-and-human-papillomavirus-co-infection-on-hpv-genotype-distribution-and-cervical-lesion-grade-in-a-semi-urban-population-in-tigoni-kenya

MLA 8th

<div>Sekkade-Kigondu, <div>Muchiri "The impact of Human Immunodeficiency Virus and Human Papillomavirus Co-Infection on HPV genotype distribution and cervical lesion grade in a semi-urban population in Tigoni, Kenya" Afribary. Afribary, 16 Jul. 2024, https://tracking.afribary.com/works/the-impact-of-human-immunodeficiency-virus-and-human-papillomavirus-co-infection-on-hpv-genotype-distribution-and-cervical-lesion-grade-in-a-semi-urban-population-in-tigoni-kenya. Accessed 14 Sep. 2024.

MLA7

<div>Sekkade-Kigondu, <div>Muchiri . "The impact of Human Immunodeficiency Virus and Human Papillomavirus Co-Infection on HPV genotype distribution and cervical lesion grade in a semi-urban population in Tigoni, Kenya". Afribary, Afribary, 16 Jul. 2024. Web. 14 Sep. 2024. < https://tracking.afribary.com/works/the-impact-of-human-immunodeficiency-virus-and-human-papillomavirus-co-infection-on-hpv-genotype-distribution-and-cervical-lesion-grade-in-a-semi-urban-population-in-tigoni-kenya >.

Chicago

<div>Sekkade-Kigondu, <div>Muchiri . "The impact of Human Immunodeficiency Virus and Human Papillomavirus Co-Infection on HPV genotype distribution and cervical lesion grade in a semi-urban population in Tigoni, Kenya" Afribary (2024). Accessed September 14, 2024. https://tracking.afribary.com/works/the-impact-of-human-immunodeficiency-virus-and-human-papillomavirus-co-infection-on-hpv-genotype-distribution-and-cervical-lesion-grade-in-a-semi-urban-population-in-tigoni-kenya